Giuseppe Ciaramella is the founder of Orbital Therapeutics. Orbital Therapeutics has raised $270M in total funding. Latest round: Series A.
Giuseppe Ciaramella is the co-founder and CEO of Orbital Therapeutics, a Cambridge, Massachusetts-based biotech company focused on developing next-gen RNA medicines. The company recently raised a $270 million Series A financing round. Prior to Orbital, Ciaramella served as president of Beam Therapeutics and was previously CSO of the infectious disease unit at Moderna, where he helped develop some of the first mRNA vaccines.
Full founder directory · Investor directory · Company funding database · Fundraising library